T. Ohyama

(3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

H. Kozono, H. Fujii, Mikiya Satoh, 2008, Bioorganic & medicinal chemistry letters.

Identification of alpha-substituted acylamines as novel, potent, and orally active mGluR5 negative allosteric modulators.

M. Moriyama, Kazumi Nishimura, Y. Numajiri, 2015, Bioorganic & medicinal chemistry letters.